Mechanisms of the placebo effect in pain and psychiatric disorders

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Pharmacogenomics Journal

• Publication date

  2016-03-22

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/tpj.2016.15PMID 27001122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BDNF Val66Met and reward-related brain function in adolescents: role for early alcohol consumption.

  2015cited by this paper
• Effects of the Mu Opioid Receptor Polymorphism (OPRM1 A118G) on Pain Regulation, Placebo Effects and Associated Personality Trait Measures

  2015cited by this paper
• Valence-Specific Effects of BDNF Val66Met Polymorphism on Dopaminergic Stress and Reward Processing in Humans

  2014cited by this paper
• Placebo response in antipsychotic clinical trials: a meta-analysis.

  2014cited by this paper
• The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients

  2013cited by this paper
• FAAH selectively influences placebo effects

  2013cited by this paper
• Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo

  2013cited by this paper
• Placebo analgesia: psychological and neurobiological mechanisms.

  2013cited by this paper
• Personality Trait Predictors of Placebo Analgesia and Neurobiological Correlates

  2013cited by this paper
• Assessing the Sources of Unreliability (Rater, Subject, Time-Point) in a Failed Clinical Trial Using Items of the Positive and Negative Syndrome Scale (PANSS)

  2013cited by this paper
• Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010.

  2013cited by this paper
• Analysis of 34 candidate genes in bupropion and placebo remission.

  2013cited by this paper
• Endogenous Opioids as Physiological Antidepressants: Complementary Role of Delta Receptors and Dopamine

  2012cited by this paper
• Genetic determinants of aggression and impulsivity in humans

  2012cited by this paper
• Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome

  2012cited by this paper
• Placebos in 19th century medicine: a quantitative analysis of the BMJ

  2012cited by this paper
• A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

  2012cited by this paper
• Amygdala Subregions Tied to SSRI and Placebo Response in Patients with Social Anxiety Disorder

  2012cited by this paper
• Whole‐Genome Sequencing in Personalized Therapeutics

  2012cited by this paper
• Brain Activation Associated with Attentional Bias in Smokers is Modulated by a Dopamine Antagonist

  2012cited by this paper
• White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia

  2012cited by this paper
• Predictors of remission with placebo using an integrated study database from patients with major depressive disorder

  2012cited by this paper
• Meta-analysis of genome-wide association studies for personality

  2012cited by this paper
• Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?

  2012cited by this paper
• Placebo response trajectories in short-term and long-term antipsychotic trials in schizophrenia.

  2011cited by this paper
• Predicting Individual Differences in Placebo Analgesia: Contributions of Brain Activity during Anticipation and Pain Experience

  2011cited by this paper
• Dorsolateral Prefrontal Cortex Drives Mesolimbic Dopaminergic Regions to Initiate Motivated Behavior

  2011cited by this paper
• Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy—magnitude and patient-related predictors

  2011cited by this paper
• How Placebos Change the Patient's Brain

  2011cited by this paper
• Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors

  2011cited by this paper
• Robust Working Memory in an Asynchronously Spiking Neural Network Realized with Neuromorphic VLSI

  2011cited by this paper
• Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trials.

  2011cited by this paper
• Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis.

  2010cited by this paper
• Imaging genetics of anxiety disorders

  2010cited by this paper
• Dispositional optimism predicts placebo analgesia.

  2010cited by this paper
• Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

  2010cited by this paper
• Serum correlates of the placebo effect in irritable bowel syndrome

  2010cited by this paper
• The different trajectories of antipsychotic response: antipsychotics versus placebo

  2010cited by this paper
• Predictors of Placebo Response in Randomized Controlled Trials of Psychotropic Drugs for Children and Adolescents with Internalizing Disorders

  2010cited by this paper
• Reward and the serotonergic system.

  2010cited by this paper
• Reproducibility of placebo analgesia: Effect of dispositional optimism

  2009cited by this paper
• The Anatomy of the Mesolimbic Reward System: A Link between Personality and the Placebo Analgesic Response

  2009cited by this paper
• Predictors of Placebo Response in Pooled Lamotrigine Neuropathic Pain Clinical Trials

  2009cited by this paper
• Genetic predictors of response to antidepressants in the GENDEP project

  2009cited by this paper
• Patient and Practitioner Influences on the Placebo Effect in Irritable Bowel Syndrome

  2009cited by this paper
• Direct Evidence for Spinal Cord Involvement in Placebo Analgesia

  2009cited by this paper
• Activation of the opioidergic descending pain control system underlies placebo analgesia.

  2009cited by this paper
• Interaction of the cannabinoid and opioid systems in the modulation of nociception

  2009cited by this paper
• Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depressive Disorder

  2009cited by this paper
• Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

  2009cited by this paper
• Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

  2008cited by this paper
• Consistency of the placebo effect.

  2008cited by this paper
• Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

  2008cited by this paper
• Do "placebo responders" exist?

  2008cited by this paper
• MAOA and the neurogenetic architecture of human aggression.

  2008cited by this paper
• ' s response to reviews Title : Spontaneous improvement in randomised clinical trials : meta-analysis of three-armed trials comparing no-treatment , placebo and active intervention

  2008cited by this paper
• Imaging the placebo response: a neurofunctional review.

  2008cited by this paper
• Trial methodology and patient characteristics did not influence the size of placebo effects on pain.

  2008cited by this paper
• The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials

  2008cited by this paper
• A118G Single Nucleotide Polymorphism of Human &mgr;-Opioid Receptor Gene Influences Pain Perception and Patient-controlled Intravenous Morphine Consumption after Intrathecal Morphine for Postcesarean Analgesia

  2008cited by this paper
• A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety

  2008cited by this paper
• Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.

  2008cited by this paper
• What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

  2008cited by this paper
• Mechanisms of placebo and placebo-related effects across diseases and treatments.

  2008cited by this paper
• Potential Predictors of Placebo Response: Lessons from a Large Database

  2007cited by this paper
• Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials.

  2007cited by this paper
• Placebo effects on human μ-opioid activity during pain

  2007cited by this paper
• Gene–gene interaction associated with neural reward sensitivity

  2007cited by this paper
• Understanding the Placebo Effect: Contributions from Neuroimaging

  2007cited by this paper
• Individual differences in reward responding explain placebo-induced expectations and effects.

  2007cited by this paper
• The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor

  2007cited by this paper
• Understanding the Placebo Effect: Contributions from Neuroimaging

  2007cited by this paper
• The μ-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers

  2006cited by this paper
• Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

  2006cited by this paper
• Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.

  2006cited by this paper
• Endogenous opioids upregulate brain‐derived neurotrophic factor mRNA through δ‐ and µ‐opioid receptors independent of antidepressant‐like effects

  2006cited by this paper
• Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram.

  2006cited by this paper
• Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.

  2006cited by this paper
• A Meta-Analysis of Early Sustained Response Rates Between Antidepressants and Placebo for the Treatment of Major Depressive Disorder

  2006cited by this paper
• Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype

  2005cited by this paper
• Placebo Effects in Oral Triptan Trials: the Scientific and Ethical Rationale for Continued use of Placebo Controls

  2005cited by this paper
• Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors

  2005cited by this paper
• A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity

  2005cited by this paper
• The placebo effect in irritable bowel syndrome trials: a meta‐analysis 1

  2005cited by this paper
• Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response.

  2005cited by this paper
• Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex

  2005cited by this paper
• Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network.

  2005cited by this paper
• Placebo mechanisms and reward circuitry: clues from Parkinson's disease.

  2004cited by this paper
• Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression

  2004cited by this paper
• Placebo-Induced Changes in fMRI in the Anticipation and Experience of Pain

  2004cited by this paper
• Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia.

  2004cited by this paper
• Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression

  2004cited by this paper
• Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder.

  2004cited by this paper
• Does elimination of placebo responders in a placebo run‐in increase the treatment effect in randomized clinical trials? A meta‐analytic evaluation

  2004cited by this paper
• Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons

  2004cited by this paper
• The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

  2003cited by this paper
• Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression

  2003cited by this paper
• Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase

  2003cited by this paper
• Placebo Response and Antidepressant Clinical Trial Outcome

  2003cited by this paper
• A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder

  2003cited by this paper

• Analyzing the Placebo Response and Identifying Influential Factors in Oral Medication Trials for Acute-Phase Schizophrenia.

  2025cites this paper
• International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement

  2025cites this paper
• The power of insulin education: enhancing pain and treatment perception in adult type 2 diabetes patients

  2025cites this paper
• Do patients with fibromyalgia syndrome and healthy people differ in their opinions on placebo effects in routine medical care?

  2025cites this paper
• Comment on: Percutaneous electrical nerve stimulation in post-mastectomy neuropathic pain: A case report

  2025cites this paper
• Pharmacogenomics: current status and future perspectives

  2023cites this paper
• Effect of prebiotic and probiotic supplementation on reduced pain in patients with fibromyalgia syndrome: a double-blind, placebo-controlled randomized clinical trial

  2023cites this paper
• A systematic review and meta‐analysis of placebo effect in clinical trials on chronic prostatitis/chronic pelvic pain syndrome

  2022cites this paper
• Transcranial direct current stimulation does not improve clinical and neurophysiological outcomes in panic disorder: A randomized sham‐controlled trial

  2022cites this paper
• Control interventions in randomised trials among people with mental health disorders.

  2022cites this paper
• Better be quiet about it! The Effects of Phantom Latency on Experienced First-Person Shooter Players

  2022cites this paper
• An observational study evaluating the efficacy of microfragmented adipose tissue in the treatment of osteoarthritis.

  2022cites this paper
• Lactobacillus ruteri compared with placebo as an adjuvant in quadruple therapy for Helicobacter pylori eradication: A randomized, double-blind, controlled trial.

  2022cites this paper
• Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials

  2022cites this paper
• Systematic Review and Meta-Analysis of the Placebo Effect and its Correlates in Obsessive Compulsive Disorder.

  2022cites this paper
• Differential power of placebo across major psychiatric disorders: a preliminary meta-analysis and machine learning study

  2021cites this paper
• The Importance of Patient Expectations: A Mixed-Methods Study of U.S. Psychiatrists

  2021cites this paper
• Nonspecific factors

  2021cites this paper
• Insulin resistance as a marker for the immune-metabolic subtype of depression.

  2021cites this paper
• Does a pretreatment with a dentine hypersensitivity mouth-rinse compensate the pain caused by professional mechanical plaque removal? A single-blind randomized controlled clinical trial

  2020cites this paper
• “Placebo by Proxy” and “Nocebo by Proxy” in Children: A Review of Parents' Role in Treatment Outcomes

  2020cites this paper
• Certainty in ascending sensory signals - The unexplored driver of analgesic placebo response.

  2020cites this paper
• Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

  2020cites this paper
• Placebo, usual care and wait-list interventions for all mental health disorders

  2019cites this paper
• What can clinicians do to improve outcomes across psychiatric treatments: a conceptual review of non-specific components

  2019cites this paper
• Use of non-invasive neuromodulation in the treatment of pain in temporomandibular dysfunction: preliminary study

  2019cites this paper
• Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

  2019cites this paper
• The Importance of the Placebo Effect in the Treatment of Different Diseases: A Vision From General Medicine

  2019cites this paper
• Less Pain, More Gain: Should Placebo Be a Clinical Therapeutic?

  2019cites this paper
• Methods for assessing and controlling placebo effects

  2019cites this paper
• Accurate pain reporting training diminishes the placebo response: Results from a randomised, double-blind, crossover trial

  2018cites this paper
• Previously reported placebo-response-associated variants do not predict patient outcomes in inflammatory disease Phase III trial placebo arms

  2018cites this paper
• Neuroanatomy of Neuropsychiatry (with Treatment Implications)

  2018cites this paper
• Adaptive multicenter designs for continuous response clinical trials in the presence of an unknown sensitive subgroup.

  2018cites this paper
• Physiological and Clinical Effects of Radiofrequency-Based Therapy

  2018cites this paper
• Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs

  2018cites this paper
• A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial

  2018cites this paper
• A Pilot Randomized Controlled Trial to Explore Cognitive and Emotional Effects of Probiotics in Fibromyalgia

  2018cites this paper
• Transcutaneous electrical nerve stimulation and placebo analgesia: is the effect the same for young and older individuals?

  2018cites this paper
• New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

  2017cites this paper
• Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response

  2017cites this paper
• The Effect of Aerosol Saline on Laboratory-Induced Dyspnea

  2017cites this paper
• Methodological Aspects of Integrative and Person-Oriented Health Care Evaluation

  2017cites this paper
• New insights on the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

  2017cites this paper